Drotrecogin Alfa (Activated)

European Journal of Anaesthesiology - United Kingdom
doi 10.1017/s0265021508004572
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Introduction: Severe Sepsis and Drotrecogin Alfa (Activated)

Critical Care
Critical CareIntensive Care Medicine
2007English

The Safety Profile of Drotrecogin Alfa (Activated)

Critical Care
Critical CareIntensive Care Medicine
2007English

Drotrecogin Alfa (Activated) May Attenuate Severe Sepsis-Associated Encephalopathy in Clinical Septic Shock

Critical Care
Critical CareIntensive Care Medicine
2010English

Drotrecogin Alfa Activated as a Treatment for Severe Sepsis in Pediatric Cancer

Bone Marrow Transplantation
TransplantationHematology
2006English

Drotrecogin Alfa in Patients With Severe Sepsis: Experience From a Tertiary Care Center in North India

Critical Care
Critical CareIntensive Care Medicine
2007English

Early Drotrecogin Alpha (Activated) Administration in Severe Sepsis Is Associated With Lower Mortality: A Retrospective Analysis of the Canadian ENHANCE Cohort

Critical Care
Critical CareIntensive Care Medicine
2009English

Alfa-Aln: Autômatos Lineares Não-Determinísticos Com Alfa-Transições

TEMA - Tendências em Matemática Aplicada e Computacional
2011English

Talassemias Alfa

Revista Brasileira de Hematologia e Hemoterapia
2006English

The Astronomical Low-Frequency Array (ALFA)

International Astronomical Union Colloquium
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy